Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2017

Open Access 01-12-2017 | Research article

Patient needs and preferences for herb-drug-disease interaction alerts: a structured interview study

Authors: Carrie M. Christensen, Rebecca S. Morris, Seraphine Chepkemoi Kapsandoy, Melissa Archer, Jinqiu Kuang, Laura Shane-McWhorter, Bruce E. Bray, Qing Zeng-Treitler

Published in: BMC Complementary Medicine and Therapies | Issue 1/2017

Login to get access

Abstract

Background

While complementary and alternative medicine (CAM) is commonly used in the United States and elsewhere, and hazardous interactions with prescription drugs can occur, patients do not regularly communicate with physicians about their CAM use. The objective of this study was to discover patient information needs and preferences for herb-drug-disease interaction alerts.

Methods

We recruited 50 people from several locations within the University of Utah Hospital to participate in this structured interview study. They were asked to provide their preferences for the herb-drug-disease interaction alerts. Qualitative methods were used to reveal the themes that emerged from the interviews.

Results

Most participants reported they had previously used, or they were currently using, CAM therapies. The majority had made the effort to inform their healthcare provider(s) about their CAM usage, although some had not. We found that most respondents were interested in receiving alerts and information about potential interactions. Many preferred to receive the alerts in a variety of ways, both in person and electronically.

Conclusions

In addition to conventional medicine, many patients regularly use complementary and alternative therapies. And yet, communication between patients and providers about CAM use is not consistent. There is a demand for interventions in health care that provide timely, integrative communication support. Delivering the herb-drug-disease alerts through multiple channels could help meet critical patient information needs.
Appendix
Available only for authorised users
Literature
3.
go back to reference Bailey RL, Gahche JJ, Lentino CV, et al. Dietary supplement use in the United States, 2003–2006. J Nutr. 2011;141(2):261–6.CrossRefPubMed Bailey RL, Gahche JJ, Lentino CV, et al. Dietary supplement use in the United States, 2003–2006. J Nutr. 2011;141(2):261–6.CrossRefPubMed
4.
go back to reference Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Rep. 2009;18:1–14. Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Rep. 2009;18:1–14.
5.
go back to reference Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep. 2008;12:1–23. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Rep. 2008;12:1–23.
6.
go back to reference Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol. 2010;55(6):515–25.CrossRefPubMedPubMedCentral Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol. 2010;55(6):515–25.CrossRefPubMedPubMedCentral
7.
go back to reference Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009;69(13):1777–98.CrossRefPubMed Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Drugs. 2009;69(13):1777–98.CrossRefPubMed
8.
9.
go back to reference Scarton LA, Zeng Q, Bray BE, Shane-McWhorter L. Feasibility and potential benefit of collecting Complementary and Alternative Medicine data through a computerized patient interview. AMIA Ann Symp Proc. 2011;2011:1217–23. Scarton LA, Zeng Q, Bray BE, Shane-McWhorter L. Feasibility and potential benefit of collecting Complementary and Alternative Medicine data through a computerized patient interview. AMIA Ann Symp Proc. 2011;2011:1217–23.
10.
go back to reference Krasuski RA, Michaelis K, Eckart RE. The cardiovascular patient’s perceptions of complementary and alternative medicine. Clin Cardiol. 2006;29(4):161–4.CrossRefPubMed Krasuski RA, Michaelis K, Eckart RE. The cardiovascular patient’s perceptions of complementary and alternative medicine. Clin Cardiol. 2006;29(4):161–4.CrossRefPubMed
11.
go back to reference Nahin RL, Byrd-Clark D, Stussman BJ, Kalyanaraman N. Disease severity is associated with the use of complementary medicine to treat or manage type-2 diabetes: data from the 2002 and 2007 National Health Interview Survey. BMC Complement Altern Med. 2012;12:193.CrossRefPubMedPubMedCentral Nahin RL, Byrd-Clark D, Stussman BJ, Kalyanaraman N. Disease severity is associated with the use of complementary medicine to treat or manage type-2 diabetes: data from the 2002 and 2007 National Health Interview Survey. BMC Complement Altern Med. 2012;12:193.CrossRefPubMedPubMedCentral
12.
go back to reference van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc. 2006;13(2):138–47.CrossRefPubMedPubMedCentral van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc. 2006;13(2):138–47.CrossRefPubMedPubMedCentral
13.
go back to reference Weingart SN, Toth M, Sands DZ, Aronson MD, Davis RB, Phillips RS. Physicians’ decisions to override computerized drug alerts in primary care. Arch Intern Med. 2003;163(21):2625–31.CrossRefPubMed Weingart SN, Toth M, Sands DZ, Aronson MD, Davis RB, Phillips RS. Physicians’ decisions to override computerized drug alerts in primary care. Arch Intern Med. 2003;163(21):2625–31.CrossRefPubMed
14.
go back to reference Phansalkar S, Desai AA, Bell D, et al. High-priority drug-drug interactions for use in electronic health records. J Am Med Inform Assoc. 2012;19(5):735–43.CrossRefPubMedPubMedCentral Phansalkar S, Desai AA, Bell D, et al. High-priority drug-drug interactions for use in electronic health records. J Am Med Inform Assoc. 2012;19(5):735–43.CrossRefPubMedPubMedCentral
15.
go back to reference Duke JD, Bolchini D. A successful model and visual design for creating context-aware drug-drug interaction alerts. AMIA Ann Symp Proc. 2011;2011:339–48. Duke JD, Bolchini D. A successful model and visual design for creating context-aware drug-drug interaction alerts. AMIA Ann Symp Proc. 2011;2011:339–48.
17.
go back to reference Perri-Moore S, Kapsandoy S, Doyon K, Hill B, Archer M, Shane-McWhorter L, Bray BE, Zeng-Treitler Q. “Automated Alerts and Reminders Targeting Patients: A Review of the Literature.” Patient Education and Counseling. 2015. Perri-Moore S, Kapsandoy S, Doyon K, Hill B, Archer M, Shane-McWhorter L, Bray BE, Zeng-Treitler Q. “Automated Alerts and Reminders Targeting Patients: A Review of the Literature.” Patient Education and Counseling. 2015.
Metadata
Title
Patient needs and preferences for herb-drug-disease interaction alerts: a structured interview study
Authors
Carrie M. Christensen
Rebecca S. Morris
Seraphine Chepkemoi Kapsandoy
Melissa Archer
Jinqiu Kuang
Laura Shane-McWhorter
Bruce E. Bray
Qing Zeng-Treitler
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2017
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-017-1630-6

Other articles of this Issue 1/2017

BMC Complementary Medicine and Therapies 1/2017 Go to the issue